Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI: 10.1093/annonc/mdu390

J. C. Soria, F. Debraud, R. Bahleda, B. Adamo, F. Andre, R. Dienstmann, A. Delmonte, R. Cereda, J. Isaacson, J. Litten, A. Allen, F. Dubois, C. Saba, R. Robert, M. D'incalci, M. Zucchetti, M. G. Camboni, J. Tabernero

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbermdu547
Pages (from-to)445
Number of pages1
JournalAnnals of Oncology
Issue number2
Publication statusPublished - Feb 1 2015

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this